Printed from Voxsanity (voxsanity.com.au) — NCT06925334 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Type 2 Diabetes
Phase 4 Type 2 Diabetes Trial, By Invitation
NCT06925334
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are willing to voluntarily sign a consent form agreeing to take part.
- People aged between 18 and 75 years old (inclusive), male or female.
- People who have been diagnosed with type 2 diabetes according to World Health Organization (WHO) standards for more than 6 months.
- People who have been using premixed human insulin or insulin-based medicines, with or without certain blood sugar-lowering tablets (excluding a specific class of medicines called secretagogues and DPP4 inhibitors), for 3 months or more, and whose blood sugar is not well controlled.
- People whose glycosylated haemoglobin (a measure of long-term blood sugar control) is above 7.0% and no higher than 8.0% at the screening visit.
- People whose Body Mass Index (BMI, a measure of body weight relative to height) is above 18 kg/m² and no higher than 35 kg/m².
- People who are willing and able to monitor their own blood sugar at home using a blood glucose meter, following the trial's requirements.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are known to be allergic to Degu insulin or any ingredients in its preparation.
- People who have used a type of diabetes medicine called a GLP-1 receptor agonist within the 3 months before screening.
- People who have had a severe low blood sugar episode causing loss of consciousness (hypoglycaemic coma) within the 3 months before screening.
- People who have had a severe episode of ketosis or diabetic ketoacidosis (a serious complication of diabetes) within the 1 month before screening.
- People who have serious diabetes complications at the time of screening, such as severe damage to the blood vessels of the eyes, a history of kidney transplant, or active problems with blood circulation in the legs or feet (such as amputation, long-lasting foot ulcers, pain when walking, or a need for procedures to restore blood flow).
- People with very high blood pressure that cannot be controlled with treatment, defined as a top reading of 180 mmHg or more and/or a bottom reading of 100 mmHg or more.
- People who have had a heart attack, uncontrolled chest pain (angina), uncontrolled irregular heartbeat, or severe heart failure in the 12 months before screening; or who have had a stroke or mini-stroke (including any type of stroke) in the 6 months before screening.
- People with significant liver or kidney problems, specifically certain liver enzyme levels (ALT, AST) more than 2.5 times the normal upper limit, or a blood marker of kidney function (serum creatinine) more than 1.5 times the normal upper limit.
- People with any other condition or illness that the trial doctor determines could interfere with the trial results, including conditions affecting the heart, lungs, digestive system, pancreas, liver, kidneys, nervous system, mental health, blood (such as blood cancers, certain types of anaemia), immune system, or any other cancer.
- People with a mental health condition, communication difficulties, or language barriers that would prevent them from fully understanding, cooperating with, or using the blood glucose meter.
- People who have used or are expected to use certain medicines that can significantly affect blood sugar levels — such as systemic corticosteroids or monoamine oxidase inhibitors — within the 3 months before screening.
- People who have taken part in another clinical trial of a drug or medical device within the 3 months before joining this study.
- People who have a history of drug abuse or alcohol dependence within the past 5 years.
- People who are known to be pregnant (based on a pregnancy test at screening), planning to become pregnant, currently breastfeeding, or women of childbearing age who are unable to use adequate contraception (defined as an IUD, oral contraceptive pill, or barrier method).
- People who the trial doctor considers unsuitable for participation in this study for any reason.
- People who have used antibiotics or probiotics within the 3 months before screening.
- People who have a personal or family history of a type of thyroid cancer called medullary thyroid cancer, or a related condition called MEN (Multiple Endocrine Neoplasia).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
By Invitation
Phase
Phase 4
Sponsor
Beijing Tsinghua Chang Gung Hospital
Registry
ClinicalTrials.gov
Start date
20 May 2024
Est. completion
31 December 2025
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
🇨🇳 China
Primary endpoints
Time to blood glucose compliance
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.